Furthermore, since these anti-myeloma agents exhibited potent anticancer effects against MM cells from patients (22), it is reasonable to assume that caspase-mediated MLKL cleavage also occurs in primary MM cells undergoing necroptotic cell death. The gene discussed is MLKL; the disease is plasma cell myeloma.